Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice.

Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice.

The cannabinoid receptor 2 (CB2) is well known for its immune modulatory role. However, recent localisation of CB2 receptors in metabolically active tissue suggests that the CB2 receptor plays a significant role in energy homeostasis. This study was designed to investigate the impact of chronic CB2...

Full description

Bibliographic Details
Main Authors:	A N A Verty, A Stefanidis, A J McAinch, D H Hryciw, Brian Oldfield
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4654496?pdf=render

Similar Items

Editorial: Peripheral Regulators of Obesity
by: Andrew J. McAinch, et al.
Published: (2019-06-01)

Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent
by: Hanlon KE, et al.
Published: (2016-04-01)

Treatment with CB2 Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice
by: Rodrigo Araujo Fraga-Silva, et al.
Published: (2013-01-01)

Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent
by: Vanderah, Todd, et al.
Published: (2016)

Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist
by: Hebaallah Mamdouh Hashiesh, et al.
Published: (2021-07-01)

CB2 receptor agonist JWH133 activates AMPK to inhibit growth of C6 glioma cells
by: Wang Feng, et al.
Published: (2019-07-01)

Anti-apoptotic and Immunomodulatory Effect of CB2 Agonist, JWH133, in a Neonatal Rat Model of Hypoxic-Ischemic Encephalopathy
by: Bhavna Gupta, et al.
Published: (2020-02-01)

Modified Alginate-Based Hydrogel as a Carrier of the CB2 Agonist JWH133 for Bone Engineering
by: Wei Zhou, et al.
Published: (2021-03-01)

Atypical cannabinoid ligands O-1602 and O-1918 administered chronically in diet-induced obesity
by: Anna C Simcocks, et al.
Published: (2019-02-01)

Cannabinoid Receptor 2 Agonist JWH-015 Inhibits Interleukin-1β-Induced Inflammation in Rheumatoid Arthritis Synovial Fibroblasts and in Adjuvant Induced Arthritis Rat via Glucocorticoid Receptor
by: Sabrina Fechtner, et al.
Published: (2019-05-01)

Beneficial metabolic effects of CB1R anti-sense oligonucleotide treatment in diet-induced obese AKR/J mice.
by: Yuting Tang, et al.
Published: (2012-01-01)

Cannabinoid CB1 Receptors Inhibit Gut-Brain Satiation Signaling in Diet-Induced Obesity
by: Donovan A. Argueta, et al.
Published: (2019-06-01)

Bioanalytical studies of the synthetic cannabinoids JWH-018 and JWH-081
by: Jörgenfelt, Kim
Published: (2011)

Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice.
by: Min He, et al.
Published: (2010-01-01)

The effects of supplementation with blueberry, cyanidin-3-O-β-glucoside, yoghurt and its peptides on obesity and related comorbidities in a diet-induced obese mouse model
by: Min Shi, et al.
Published: (2019-05-01)

Combined Neuroprotective Action of JWH-015 and AM251 in the CA1 Hippocampal Area of Rat Model of Transient Global Cerebral Ischemia
by: Maryam Shiasi, et al.
Published: (2018-04-01)

Anti-Obesity Effect of Pine Needle Extract on High-Fat Diet-Induced Obese Mice
by: Eun A Kim, et al.
Published: (2021-04-01)

Anti-obesity effect of Yangkyuksanwha-tang in high-fat diet-induced obese mice
by: Young-Mee Koh, et al.
Published: (2019-09-01)

Mechanisms for the anti-obesity actions of bofutsushosan in high-fat diet-fed obese mice
by: Shinjiro Kobayashi, et al.
Published: (2017-03-01)

Decreasing CB1 receptor signaling in Kupffer cells improves insulin sensitivity in obese mice
by: Tony Jourdan, et al.
Published: (2017-11-01)

The antinociceptive effects of JWH-015 in chronic inflammatory pain are produced by nitric oxide-cGMP-PKG-KATP pathway activation mediated by opioids.
by: Roger Negrete, et al.
Published: (2011-01-01)

Anti-inflammatory and antinociceptive effects of the selective cannabinoid CB2 receptor agonist ABK5
by: Yaliang Tang, et al.
Published: (2021-04-01)

Characterization of combined linagliptin and Y2R agonist treatment in diet-induced obese mice
by: Henrik H. Hansen, et al.
Published: (2021-04-01)

Mice Expressing a "Hyper-Sensitive" Form of the Cannabinoid Receptor 1 (CB1) Are Neither Obese Nor Diabetic.
by: David J Marcus, et al.
Published: (2016-01-01)

Cardiovascular effects of JWH-018 from synthetic cannabinoids [Sentetik kannabinoidlerden JWH-018in kardiyovaskuler etkileri]
by: Hakan Parlakpinar, et al.
Published: (2016-12-01)

Data on individual metabolites of synthetic cannabinoids JWH-018, JWH-073 and AM2201 by Cunninghamella elegans
by: Shimpei Watanabe, et al.
Published: (2016-06-01)

Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
by: Mikkel Søes Ibsen, et al.
Published: (2019-04-01)

Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle.
by: Sergio Arrabal, et al.
Published: (2015-01-01)

The Peroxisome Proliferator-Activated Receptor α (PPARα) Agonist Pemafibrate Protects against Diet-Induced Obesity in Mice
by: Masaya Araki, et al.
Published: (2018-07-01)

Tocotrienols and Whey Protein Isolates Substantially Increase Exercise Endurance Capacity in Diet -Induced Obese Male Sprague-Dawley Rats.
by: Andrew C Betik, et al.
Published: (2016-01-01)

Anti-Obesity and Anti-Diabetic Effects of Acacia Polyphenol in Obese Diabetic KKAy Mice Fed High-Fat Diet
by: Nobutomo Ikarashi, et al.
Published: (2011-01-01)

Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice.
by: Ji-Hee Kang, et al.
Published: (2013-01-01)

Anti-obesity effect of Antrodia cinnamomea water extract in high-fat diet induced obese mice
by: Hui Ling Wang, et al.
Published: (2014)

Blueberry as a source of bioactive compounds for the treatment of obesity, type 2 diabetes and chronic inflammation
by: Min Shi, et al.
Published: (2017-03-01)

Peripheral CB1 Receptor Neutral Antagonist, AM6545, Ameliorates Hypometabolic Obesity and Improves Adipokine Secretion in Monosodium Glutamate Induced Obese Mice
by: Haiming Ma, et al.
Published: (2018-03-01)

The Role of Atypical Cannabinoid Ligands O-1602 and O-1918 on Skeletal Muscle Homeostasis with a Focus on Obesity
by: Anna C. Simcocks, et al.
Published: (2020-08-01)

Cannabinoid Type-2 Receptor Agonist, JWH133 May Be a Possible Candidate for Targeting Infection, Inflammation, and Immunity in COVID-19
by: Niraj Kumar Jha, et al.
Published: (2021-08-01)

Characterization of Subtype Selective Cannabinoid CB<sub>2</sub> Receptor Agonists as Potential Anti-Inflammatory Agents
by: Yaliang Tang, et al.
Published: (2021-04-01)

Anti-Obesity Effects of the Flower of <i>Prunus persica</i> in High-Fat Diet-Induced Obese Mice
by: Jungbin Song, et al.
Published: (2019-09-01)

Comparison With The Anti-obesity Effect Of Xanthigen And Superba Krill Oil In High Fat Diet-induced Obese Mice
by: Jain-Sin Hou, et al.
Published: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vkmv545t3v46alu5dte103k47i